Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

Definium Therapeutics, Inc. Filed Acc 0001422849-26-000171

Stakes reported in this filing

Reporting person Shares Of the class
Capital World Investors 8,255,584 6.1%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…